Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Arcadia Biosciences (RKDA) stocks in Canada

Learn how to easily invest in Arcadia Biosciences stocks.

Arcadia Biosciences is an agricultural inputs business based in the US. Arcadia Biosciences stocks (RKDA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.72 – a decrease of 13.35% over the previous week. Arcadia Biosciences employs 58 staff and has a trailing 12-month revenue of around $11.7 million.

How to buy shares in Arcadia Biosciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – RKDA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Is it a good time to buy Arcadia Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

How has Coronavirus impacted Arcadia Biosciences's stock price?

Since the stock market crash in March caused by coronavirus, Arcadia Biosciences's stock price has had significant negative movement.

Its last market close was $0.9532, which is 80.78% down on its pre-crash value of $4.96 and 141.29% down on the lowest point reached during the March crash when the stocks fell as low as $2.3.

If you had bought $1,000 worth of Arcadia Biosciences stocks at the start of February 2020, those stocks would have been worth $509.18 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $194.14.

Arcadia Biosciences stock price (NASDAQ:RKDA)

Use our graph to track the performance of RKDA stocks over time.

Arcadia Biosciences shares at a glance

Information last updated 2022-01-17.
Latest market close$0.95
52-week range$0.97 - $6.40
50-day moving average $1.34
200-day moving average $2.18
Wall St. target price$5.25
PE ratio 5.4211
Dividend yield N/A (0%)
Earnings per share (TTM) $0.19

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.

Compare up to 4 providers

Online stock trading

Arcadia Biosciences price performance over time

Historical closes compared with the close of $0.9532 from 2022-01-18

1 week (2022-01-12) -15.65%
1 month (2021-12-17) -9.22%
3 months (2021-10-19) -54.39%
6 months (2021-07-19) -61.25%
1 year (2021-01-19) -68.44%
2 years (2020-01-17) -81.88%
3 years (2019-01-18) 3.66
5 years (2017-01-19) 1.01

Is Arcadia Biosciences under- or over-valued?

Valuing Arcadia Biosciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Arcadia Biosciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Arcadia Biosciences's P/E ratio

Arcadia Biosciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 5x. In other words, Arcadia Biosciences shares trade at around 5x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Arcadia Biosciences financials

Revenue TTM $11.7 million
Gross profit TTM $-814,000
Return on assets TTM -22.3%
Return on equity TTM 7.78%
Profit margin 29.99%
Book value $1.80
Market capitalisation $22.8 million

TTM: trailing 12 months

Arcadia Biosciences share dividends

We're not expecting Arcadia Biosciences to pay a dividend over the next 12 months.

Have Arcadia Biosciences's shares ever split?

Arcadia Biosciences's shares were split on a 1:20 basis on 23 January 2018. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Arcadia Biosciences shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Arcadia Biosciences shares which in turn could have impacted Arcadia Biosciences's share price.

Arcadia Biosciences share price volatility

Over the last 12 months, Arcadia Biosciences's shares have ranged in value from as little as $0.972 up to $6.4. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Arcadia Biosciences's is -0.6229. This would suggest that Arcadia Biosciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Arcadia Biosciences has bucked the trend.

Arcadia Biosciences overview

Arcadia Biosciences, Inc. engages in developing various crop productivity traits primarily in hemp, wheat, and soybean. The company's crop productivity traits are designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its products include GoodHemp, a commercial pipeline of non-GMO hemp seed varieties developed with modern crop innovation tools focused on genetic improvement of hemp; GoodWheat that redesigns wheat as a functional food adding value to the wheat supply chain by enabling a range of choices to meet consumer demands; and nutritional oils, such as gamma linolenic acid oils. The company has collaborations with Ardent Mills, LLC, Corteva AgriScience, and Arista Cereal Seeds Pty Ltd, and Bay State Milling Company. It operates in the United States, Argentina, Canada, Africa, Austria, and India. The company was incorporated in 2002 and is headquartered in Davis, California.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Ask an Expert

You must be logged in to post a comment.

Go to site